Plain-English translation of NCT06822439 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a new wearable device that can monitor your baby's heart rate from home using a technology called non-invasive fetal electrocardiography (NIFECG). Instead of going to the hospital for weekly fetal monitoring appointments, you would wear this remote monitoring device yourself. The goal is to see if this device works well and is practical for pregnant people with high-risk pregnancies.
Currently, pregnant people with high-risk pregnancies need to go to the hospital once a week or more to have their baby's heart rate monitored using ultrasound machines. This new wearable technology could allow the same monitoring to happen safely at home, making care more convenient and reducing trips to the hospital.
You likely qualify if…
You likely don't qualify if…
You would wear a remote monitoring device as directed by the research team, likely during periods when you would normally go to the hospital for fetal monitoring. The device works like an adhesive patch or band that sits on your skin and records your baby's heart rate. You may be asked to answer questions about how easy or difficult the device was to use and whether you found it acceptable as an alternative to traditional hospital visits.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
United States
Collaborators
Biorithm Pte Ltd
Enrollment target
~50 participants
Started
May 2025
Primary completion
December 2026
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ethan Litman, MD, MS
Beth Israel Deaconess Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.